Selected research
Industry Research
Telmisartan Industry Research Report 2026
Market perspective
The global Telmisartan market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Telmisartan is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Telmisartan is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Telmisartan is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Telmisartan include Beijing Wansheng Pharmaceutical, Boehringer Ingelheim, Hema Pharmaceuticals Pvt, Nippon Boehringer Ingelheim, Reddy's Laboratories (UK), Astellas Pharma Inc, Bayer, GSK and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Telmisartan market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Telmisartan Market by Company
Beijing Wansheng Pharmaceutical
Boehringer Ingelheim
Hema Pharmaceuticals Pvt
Nippon Boehringer Ingelheim
Reddy's Laboratories (UK)
Astellas Pharma Inc
Bayer
GSK
Pfizer
Mylan
Novartis
Teva
Takeda
Abbott
Telmisartan Segment by Type
Injection
Freeze-Dried Powder
Telmisartan Segment by Application
Hospital
Clinic
Others
Telmisartan Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Telmisartan market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Telmisartan and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Telmisartan.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Telmisartan manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Telmisartan by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Telmisartan in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injection
- Freeze-Dried Powder
Applications
- Hospital
- Clinic
- Others
Companies covered
- Beijing Wansheng Pharmaceutical
- Boehringer Ingelheim
- Hema Pharmaceuticals Pvt
- Nippon Boehringer Ingelheim
- Reddy's Laboratories (UK)
- Astellas Pharma Inc
- Bayer
- GSK
- Pfizer
- Mylan
- Novartis
- Teva
- Takeda
- Abbott
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Telmisartan Market Size (2021-2032)
- 2.2.2 Global Telmisartan Sales (2021-2032)
- 2.2.3 Global Telmisartan Market Average Price (2021-2032)
- 2.3 Telmisartan by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Injection
- 2.3.3 Freeze-Dried Powder
- 2.4 Telmisartan by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Telmisartan Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Telmisartan Sales (Tons) of Manufacturers (2021-2026)
- 3.3 Global Telmisartan Revenue of Manufacturers (2021-2026)
- 3.4 Global Telmisartan Average Price by Manufacturers (2021-2026)
- 3.5 Global Telmisartan Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Telmisartan, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Telmisartan, Product Type & Application
- 3.8 Global Manufacturers of Telmisartan, Established Date
- 3.9 Global Telmisartan Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Beijing Wansheng Pharmaceutical
- 4.1.1 Beijing Wansheng Pharmaceutical Company Information
- 4.1.2 Beijing Wansheng Pharmaceutical Business Overview
- 4.1.3 Beijing Wansheng Pharmaceutical Telmisartan Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Beijing Wansheng Pharmaceutical Telmisartan Product Portfolio
- 4.1.5 Beijing Wansheng Pharmaceutical Recent Developments
- 4.2 Boehringer Ingelheim
- 4.2.1 Boehringer Ingelheim Company Information
- 4.2.2 Boehringer Ingelheim Business Overview
- 4.2.3 Boehringer Ingelheim Telmisartan Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Boehringer Ingelheim Telmisartan Product Portfolio
- 4.2.5 Boehringer Ingelheim Recent Developments
- 4.3 Hema Pharmaceuticals Pvt
- 4.3.1 Hema Pharmaceuticals Pvt Company Information
- 4.3.2 Hema Pharmaceuticals Pvt Business Overview
- 4.3.3 Hema Pharmaceuticals Pvt Telmisartan Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Hema Pharmaceuticals Pvt Telmisartan Product Portfolio
- 4.3.5 Hema Pharmaceuticals Pvt Recent Developments
- 4.4 Nippon Boehringer Ingelheim
- 4.4.1 Nippon Boehringer Ingelheim Company Information
- 4.4.2 Nippon Boehringer Ingelheim Business Overview
- 4.4.3 Nippon Boehringer Ingelheim Telmisartan Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Nippon Boehringer Ingelheim Telmisartan Product Portfolio
- 4.4.5 Nippon Boehringer Ingelheim Recent Developments
- 4.5 Reddy's Laboratories (UK)
- 4.5.1 Reddy's Laboratories (UK) Company Information
- 4.5.2 Reddy's Laboratories (UK) Business Overview
- 4.5.3 Reddy's Laboratories (UK) Telmisartan Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Reddy's Laboratories (UK) Telmisartan Product Portfolio
- 4.5.5 Reddy's Laboratories (UK) Recent Developments
- 4.6 Astellas Pharma Inc
- 4.6.1 Astellas Pharma Inc Company Information
- 4.6.2 Astellas Pharma Inc Business Overview
- 4.6.3 Astellas Pharma Inc Telmisartan Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Astellas Pharma Inc Telmisartan Product Portfolio
- 4.6.5 Astellas Pharma Inc Recent Developments
- 4.7 Bayer
- 4.7.1 Bayer Company Information
- 4.7.2 Bayer Business Overview
- 4.7.3 Bayer Telmisartan Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Bayer Telmisartan Product Portfolio
- 4.7.5 Bayer Recent Developments
- 4.8 GSK
- 4.8.1 GSK Company Information
- 4.8.2 GSK Business Overview
- 4.8.3 GSK Telmisartan Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 GSK Telmisartan Product Portfolio
- 4.8.5 GSK Recent Developments
- 4.9 Pfizer
- 4.9.1 Pfizer Company Information
- 4.9.2 Pfizer Business Overview
- 4.9.3 Pfizer Telmisartan Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Pfizer Telmisartan Product Portfolio
- 4.9.5 Pfizer Recent Developments
- 4.10 Mylan
- 4.10.1 Mylan Company Information
- 4.10.2 Mylan Business Overview
- 4.10.3 Mylan Telmisartan Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Mylan Telmisartan Product Portfolio
- 4.10.5 Mylan Recent Developments
- 4.11 Novartis
- 4.11.1 Novartis Company Information
- 4.11.2 Novartis Business Overview
- 4.11.3 Novartis Telmisartan Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Novartis Telmisartan Product Portfolio
- 4.11.5 Novartis Recent Developments
- 4.12 Teva
- 4.12.1 Teva Company Information
- 4.12.2 Teva Business Overview
- 4.12.3 Teva Telmisartan Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Teva Telmisartan Product Portfolio
- 4.12.5 Teva Recent Developments
- 4.13 Takeda
- 4.13.1 Takeda Company Information
- 4.13.2 Takeda Business Overview
- 4.13.3 Takeda Telmisartan Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Takeda Telmisartan Product Portfolio
- 4.13.5 Takeda Recent Developments
- 4.14 Abbott
- 4.14.1 Abbott Company Information
- 4.14.2 Abbott Business Overview
- 4.14.3 Abbott Telmisartan Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Abbott Telmisartan Product Portfolio
- 4.14.5 Abbott Recent Developments
5 Global Telmisartan Market Scenario by Region
- 5.1 Global Telmisartan Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Telmisartan Sales by Region: 2021-2032
- 5.2.1 Global Telmisartan Sales by Region: 2021-2026
- 5.2.2 Global Telmisartan Sales by Region: 2027-2032
- 5.3 Global Telmisartan Revenue by Region: 2021-2032
- 5.3.1 Global Telmisartan Revenue by Region: 2021-2026
- 5.3.2 Global Telmisartan Revenue by Region: 2027-2032
- 5.4 North America Telmisartan Market Facts & Figures by Country
- 5.4.1 North America Telmisartan Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Telmisartan Sales by Country (2021-2032)
- 5.4.3 North America Telmisartan Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Telmisartan Market Facts & Figures by Country
- 5.5.1 Europe Telmisartan Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Telmisartan Sales by Country (2021-2032)
- 5.5.3 Europe Telmisartan Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Telmisartan Market Facts & Figures by Country
- 5.6.1 Asia Pacific Telmisartan Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Telmisartan Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Telmisartan Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Telmisartan Market Facts & Figures by Country
- 5.7.1 South America Telmisartan Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Telmisartan Sales by Country (2021-2032)
- 5.7.3 South America Telmisartan Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Telmisartan Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Telmisartan Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Telmisartan Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Telmisartan Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Telmisartan Sales by Type (2021-2032)
- 6.1.1 Global Telmisartan Sales by Type (2021-2032) & (Tons)
- 6.1.2 Global Telmisartan Sales Market Share by Type (2021-2032)
- 6.2 Global Telmisartan Revenue by Type (2021-2032)
- 6.2.1 Global Telmisartan Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Telmisartan Revenue Market Share by Type (2021-2032)
- 6.3 Global Telmisartan Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Telmisartan Sales by Application (2021-2032)
- 7.1.1 Global Telmisartan Sales by Application (2021-2032) & (Tons)
- 7.1.2 Global Telmisartan Sales Market Share by Application (2021-2032)
- 7.2 Global Telmisartan Revenue by Application (2021-2032)
- 7.2.1 Global Telmisartan Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Telmisartan Revenue Market Share by Application (2021-2032)
- 7.3 Global Telmisartan Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Telmisartan Value Chain Analysis
- 8.1.1 Telmisartan Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Telmisartan Production Mode & Process
- 8.2 Telmisartan Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Telmisartan Distributors
- 8.2.3 Telmisartan Customers
9 Global Telmisartan Analyzing Market Dynamics
- 9.1 Telmisartan Industry Trends
- 9.2 Telmisartan Industry Drivers
- 9.3 Telmisartan Industry Opportunities and Challenges
- 9.4 Telmisartan Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst